Onyx Scientific is a CDMO that helps pharmaceutical and biotech companies across the globe, accelerate candidates from discovery to manufacturing. A preferred partner of many of the world’s top pharmaceutical firms, it operates from MHRA and FDA licensed sites in UK and India. Supporting clients from medicinal chemistry and pre-clinical through Phase I-III, scaling-up to large scale commercial API production. Its UK-based labs deal with complex chemistry and deliver early stage programs involving custom synthesis, lead optimization, process development, solid-state chemistry and GMP API synthesis. It is then able to scale-up, internally tech transfer and provide increased efficiency for clients from its commercial sites in India.
There is no investment information
No recent news or press coverage available for Onyx Scientific.